4/A//SEC Filing
VAN VOORHEES SETH 4/A
Accession 0001415889-22-012650
CIK 0001719406other
Filed
Dec 18, 7:00 PM ET
Accepted
Dec 19, 7:08 AM ET
Size
8.7 KB
Accession
0001415889-22-012650
Insider Transaction Report
Form 4/AAmended
VAN VOORHEES SETH
Chief Financial Officer
Transactions
- Purchase
Common Stock, par value $0.001 per share
2022-11-25$1.12/sh+8,716$9,762→ 8,716 total - Purchase
Common Stock, par value $0.001 per share
2022-11-25$1.10/sh+600$660→ 9,316 total - Purchase
Common Stock, par value $0.001 per share
2022-11-25$1.11/sh+7,021$7,793→ 16,337 total
Footnotes (4)
- [F1]The form of ownership has been changed from Indirect to Direct. The original Form 4 stated that these shares were purchased though a 401(k) plan. This Form 4/A is being filed to correct this error.
- [F2]The form of ownership has been changed from Indirect to Direct. The original Form 4 stated that these shares were purchased though a 401(k) plan. This Form 4/A is being filed to correct this error.
- [F3]Total number of shares held is reduced by 40 shares to correct an arithmetic error in the original Form 4.
- [F4]The form of ownership has been changed from Indirect to Direct. The original Form 4 stated that these shares were purchased though a 401(k) plan. This Form 4/A is being filed to correct this error.
Documents
Issuer
NRX Pharmaceuticals, Inc.
CIK 0001719406
Entity typeother
Related Parties
1- filerCIK 0001284934
Filing Metadata
- Form type
- 4/A
- Filed
- Dec 18, 7:00 PM ET
- Accepted
- Dec 19, 7:08 AM ET
- Size
- 8.7 KB